Metal-based complexes against SARS-CoV-2

Kyriacos Ioannou, Manos C. Vlasiou

Research output: Contribution to journalReview articlepeer-review


The first appearance of SARS-CoV-2 is dated back to 2019. This new member of the coronavirus family has caused more than 5 million deaths worldwide up until the end of January 2022. At the moment, and after intensive vaccination programmes throughout the world, the pandemic is still active, whilst new mutations constantly appear. Researchers are working intensively to discover antiviral drugs to combat the severe cases in intensive care units, giving the overloaded hospital units a breather. Alongside various research projects focusing on developing small pharmaceutical molecules, a significant proportion of the research community has shifted towards paying attention to metal drugs. In this small review, we make brief reference to the use of metal drugs in therapeutics and provide some examples of metal drugs that are of extreme interest in the current pandemic. At the same time, we will also examine some of their promising mechanisms of action and possible effectiveness against COVID-19.

Original languageEnglish
Publication statusAccepted/In press - 2022


  • Antiviral
  • Biological activity
  • HIV
  • Influenza
  • Metal complexes
  • SARS-CoV-2


Dive into the research topics of 'Metal-based complexes against SARS-CoV-2'. Together they form a unique fingerprint.

Cite this